Neoleukin Therapeutics Inc

NGNE NASDAQ Santé & Biotech États-Unis US64135M1053
26.95 $
0.26 %

Neoleukin Therapeutics Inc est dédiée au développement de thérapies immunologiques innovantes pour les cancers et les maladies auto-immunes.

Performance & Momentum

6 Months 32.77 %
1 Year 65.76 %
3 Years 69.43 %
5 Years 85.72 %

Similar stocks to Neoleukin Therapeutics Inc

Anantys Community

Be the first to share your analysis on Neoleukin Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases